STRONGBRIDGE BIOPHARMA PLC
STRONGBRIDGE BIOPHARMA PLC
Share · IE00BYZ5XL97 · SBBP · A14Z67 (XNAS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % 0,00 % -41,69 %

Company Profile for STRONGBRIDGE BIOPHARMA PLC Share

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs. The company offers Keveyis, an oral carbonic anhydrase inhibitor for treating hyperkalemic, hypokalemic, and related variants of primary periodic paralysis in the United States. Its clinical-stage product candidates include Recorlev, a cortisol synthesis inhibitor, which is in a Phase III clinical trials that for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is headquartered in Trevose, Pennsylvania.

Company Data

Name STRONGBRIDGE BIOPHARMA PLC
Company Strongbridge Biopharma plc
Symbol SBBP
Website http://www.strongbridgebio.com
Primary Exchange XNAS NASDAQ
WKN A14Z67
ISIN IE00BYZ5XL97
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Matthew Pauls
Country United States of America
Currency USD
Employees 0,1 T
Address 900 Northbrook Dr Ste 200, Trevose
IPO Date 2015-09-10

Ticker Symbols

Name Symbol
NASDAQ SBBP

More Shares

Investors who STRONGBRIDGE BIOPHARMA PLC hold also have the following shares in their portfolio:
DEVA FINANCING PLC CLASS A4 ASSET BKD FRN 19/11/53
DEVA FINANCING PLC CLASS A4 ASSET BKD FRN 19/11/53 Bond
HSBC HLDGS 23/34 FLR
HSBC HLDGS 23/34 FLR Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025